Trial · NCT03033745
Adverse events470
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 470
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Hot flush | Vascular disorders | IgPro20 (Pump-assisted Volume) 25 mL | 0 | 15 | 0 |
| other | Hot flush | Vascular disorders | IgPro20 (Pump-assisted Volume) 40 mL | 1 | 12 | 1 |
| other | Hot flush | Vascular disorders | IgPro20 (Pump-assisted Volume) 50 mL | 0 | 11 | 0 |
| other | Hot flush | Vascular disorders | IgPro20 (Pump-assisted Flow Rate) 25 mL/h | 0 | 18 | 0 |
| other | Hot flush | Vascular disorders | IgPro20 (Pump-assisted Flow Rate) 50 mL/h | 0 | 14 | 0 |
| other | Hot flush | Vascular disorders | IgPro20 (Pump-assisted Flow Rate) 75 mL/h | 0 | 13 | 0 |
| other | Hot flush | Vascular disorders | IgPro20 (Pump-assisted Flow Rate) 100 mL/h | 0 | 12 | 0 |
| other | Hot flush | Vascular disorders | IgPro20 (Manual Push Flow Rate) 30 mL/h | 0 | 16 | 0 |
| other | Hot flush | Vascular disorders | IgPro20 (Manual Push Flow Rate) 60 mL/h | 0 | 16 | 0 |
| other | Hot flush | Vascular disorders | IgPro20 (Manual Push Flow Rate) 120 mL/h | 0 | 14 | 0 |
| other | Hypertension | Vascular disorders | IgPro20 (Pump-assisted Volume) 25 mL | 0 | 15 | 0 |
| other | Hypertension | Vascular disorders | IgPro20 (Pump-assisted Volume) 40 mL | 0 | 12 | 0 |
| other | Hypertension | Vascular disorders | IgPro20 (Pump-assisted Volume) 50 mL | 0 | 11 | 0 |
| other | Hypertension | Vascular disorders | IgPro20 (Pump-assisted Flow Rate) 25 mL/h | 0 | 18 | 0 |
| other | Hypertension | Vascular disorders | IgPro20 (Pump-assisted Flow Rate) 50 mL/h | 0 | 14 | 0 |
| other | Hypertension | Vascular disorders | IgPro20 (Pump-assisted Flow Rate) 75 mL/h | 0 | 13 | 0 |
| other | Hypertension | Vascular disorders | IgPro20 (Pump-assisted Flow Rate) 100 mL/h | 0 | 12 | 0 |
| other | Hypertension | Vascular disorders | IgPro20 (Manual Push Flow Rate) 30 mL/h | 0 | 16 | 0 |
| other | Hypertension | Vascular disorders | IgPro20 (Manual Push Flow Rate) 60 mL/h | 1 | 16 | 1 |
| other | Hypertension | Vascular disorders | IgPro20 (Manual Push Flow Rate) 120 mL/h | 0 | 14 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03033745/events